Zegenex secures a $215,000 funding round from Richard King Mellon Foundation to enhance chronic wound treatments with Zegen-15, aiming for formulation optimization and preclinical testing.
Amount Raised
$215,000
Round Type
Pre-Seed
Investors
Description
Zegenex announced it has received a $215,000 social-mission investment from the Richard King Mellon Foundation. The funding will support formulation optimization and preclinical testing of Zegen-15, a small-molecule cream designed to treat chronic wounds. Chronic wounds like diabetic foot ulcers pose a significant medical challenge, affecting millions. The company aims to provide cost-effective solutions to improve patient outcomes.
Quick answer
Zegenex raised $215,000 in a Pre-Seed round, dated December 11, 2025. Investors: Richard King Mellon Foundation. Zegenex is based in Pittsburgh, Pennsylvania, United States.
- How much did Zegenex raise?
- Zegenex raised $215,000 in a Pre-Seed round on December 11, 2025.
- Who invested in Zegenex?
- Richard King Mellon Foundation is named as investors in this round.
- What does Zegenex do?
- Zegenex is a biotechnology company based in Pittsburgh that develops innovative therapies to accelerate wound healing.
- Where is Zegenex based and how big is it?
- Zegenex is based in Pittsburgh, Pennsylvania, United States. Fundz records about 2 employees.
- Who are the decision-makers at Zegenex?
- Fundz holds 1 contact at Zegenex, including the Co-Founder & CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Zegenex that raised within 45 days of this round, from Fundz verified event records.
- Axogen raised $124M (Post-IPO Equity) on January 23, 2026.
- Pi Health raised $8.6M on January 23, 2026.
- Cancilico raised $2.9M (Seed) on January 22, 2026.
- Mendra raised $82M (Series A) on January 22, 2026.
- Corxel Pharmaceuticals raised $287M (Series D) on January 22, 2026.
- Infinitopes raised $15M (Seed) on January 21, 2026.
Who to call at Zegenex, and when
A new round usually means Zegenex is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Zegenex raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Zegenex, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Zegenex. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Zegenex raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Zegenex raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.